You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Real-time Multimodal Diffuse Reflectance and Polarization Imaging Based Nerve Identification in Surgical Field of View
SBC: YAYA SCIENTIFIC LLC Topic: NIBIBPROJECT SUMMARY We propose to develop a novel non-contact, label-free multimodality imager that provides real-time intraoperative identification of nerves within the surgical field-of-view to facilitate the prevention of unintended nerve damage (termed iatrogenic nerve injury) during surgical procedures, as they are a major source of postsurgical complications, e.g., chronic pain. In the United St ...
STTR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Optimizing Small Molecule Mechanomimetics to Treat Age-related Osteoporosis.
SBC: OAK RIDGE THERAPEUTIC DISCOVERY LLC Topic: NIAAbstract There is an unmet need to develop treatments for senile osteoporosis, a disorder characterized by an age-related reciprocal decrease in osteogenesis and increase in bone marrow fat. Senile osteoporosis resembles disuse osteopenia, suggesting its pathogenesis involves impaired bone mechanosensing. We discovered that the polycystin heterotrimeric complex (1PC1+3PC2) functions as a mechanose ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Developing a selective TRPC3 ion channel inhibitor for epilepsy treatment
SBC: SEAK Therapeutics, LLC Topic: 106Project SummaryEpilepsy is one of the most common brain disorders. Current drugs have limited efficacy. Identifying new targeted drugs that can be used as safer, more effective therapies is in urgent unmet need. Selective inhibition of the transient receptor potential canonical 3 (TRPC3) emerges as a novel strategy to impede epilepsy. However, the currently best selective TRPC3 inhibitor, Pyr3, ha ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Lightweight Multifunctional EMI-shielding Coatings Enabled by Domestic, Sustainable, & Low-Cost Carbon Nanotubes
SBC: SKYNANO LLC Topic: AFX23DTCSO1Electromagnetic Interface (EMI) Shielding is critical for maintenance of critical infrastructure and to prevent from external signals from disrupting electronics devices. State of the art EMI shielding includes heavy metal-based materials, which add mass
STTR Phase I 2023 Department of DefenseAir Force -
Domestic source of semiconducting carbon nanotubes for advanced chemical sensors
SBC: AMERICAN NANOTECHNOLOGIES INC Topic: AFX23DTCSO1Semiconducting carbon nanotubes (s-CNTs) have been used to build thin, flexible sensors relevant to the DoD mission. These include both physical sensors, such as stress/strain and temperature sensors, and chemical sensors, such as biomarker or toxic compo
STTR Phase I 2023 Department of DefenseAir Force -
A New Rapid Conversion Technology for High Volume, Low Cost Carbon Fiber
SBC: ReMaxCo Technologies, LLC Topic: AF21ATCSO2Carbon fiber is now used extensively in military vehicles, structures and equipment, and its use will only expand due to its combination of light weight and high strength. However, the challenge of widespread adoption both in the military and in the comme
STTR Phase I 2022 Department of DefenseAir Force -
Chemical Sensors for Human Performance Monitoring and Force Protection
SBC: AMERICAN NANOTECHNOLOGIES INC Topic: AF21BTCSO1Chemical sensors based on functionalized carbon nanotubes (CNTs) have been demonstrated to detect battlefield-relevant biomarkers and other analytes. This includes quantification of neurological and cardiological stress markers as well as detection of har
STTR Phase I 2022 Department of DefenseAir Force -
Zero Vulnerability Technology: Leveraging Micropatching and Intelligent Software Scrambling for Next Generation Northern Command Application Security
SBC: ARMS CYBER DEFENSE, INC. Topic: AF20CTCSO1Homogeneous software applications employed throughout NORTHCOM and Platform One pose a huge opportunity for adversaries to scale exploits within the defense ecosystem. Unmanned Aerial System (UAS) applications specifically pose a huge attack vector due to
STTR Phase II 2022 Department of DefenseAir Force -
Morphing Rocket Throat
SBC: GLOYER-TAYLOR LABORATORIES INC Topic: MDA21T005Using modern additive manufacturing technology, GTL proposes to develop a geometry based thermal management system to enable the development of a Morphing Rocket Throat. With this capability, rocket motors will be able to achieve the same type of throttling provided by pintle nozzles, but without the complexity and mass of a pintle. In the Phase I effort, GTL and UTK will develop a conceptual desi ...
STTR Phase I 2022 Department of DefenseMissile Defense Agency -
eQ Propulsor for Drone Applications
SBC: WHISPER AERO INC Topic: AFX20DTCSO1In this Phase II STTR, Whisper Aero is proposing novel ultra-quiet high-performance propulsors that can be applied to Group I, II, and III UAS and consumer drones. In Phase I, Whisper Aero successfully designed, built, and tested an initial design using a comprehensive suite of low-Reynolds number aerodynamic design tools, aero-structural static & modal analyses, rapid manufacturing techniques, a ...
STTR Phase II 2022 Department of DefenseAir Force